Gottlieb Wants More Systematic Updates Of Regulations
Executive Summary
The US FDA commissioner says the agency has gone through sporadic reviews of regulations, but he would like to see a more systematic process to continuously evaluate whether regulations should be modified or withdrawn.
You may also be interested in...
OMB: US FDA Has Withdrawn At least 10 Regulations In Response To Trump 2-for-1 Order
Following several executive orders from the president intended to remove regulations from the federal books, the White House tells Medtech Insight it has already pulled multiple rules from FDA and other agencies – and that number may still grow by the time the Office of Management and Budget has completed an agency-wide review.
US FDA To Publish Own Datasets In Latest Signal Of Enhanced Transparency
Adverse event reporting data will also be more readily available, Commissioner Scott Gottlieb says.
US FDA To Public: Help Us Streamline Our Regs
The agency is calling on all regulated industry and the public in general to recommend regulations that should be withdrawn, modified or replaced in line with President Trump's executive order from earlier this year to remove two regulations for every new one implemented.